Ardent Health, Inc. (NYSE:ARDT) Receives $19.33 Consensus Price Target from Brokerages

Ardent Health, Inc. (NYSE:ARDT) has been given an average recommendation of “Moderate Buy” by the twelve analysts that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, one has given a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $19.3273.

ARDT has been the topic of a number of research analyst reports. JPMorgan Chase & Co. decreased their price objective on shares of Ardent Health from $18.00 to $15.00 and set a “neutral” rating on the stock in a report on Monday, August 11th. UBS Group assumed coverage on shares of Ardent Health in a research report on Wednesday, September 10th. They set a “buy” rating and a $17.00 price target for the company. Weiss Ratings restated a “sell (d+)” rating on shares of Ardent Health in a report on Wednesday, October 8th. KeyCorp dropped their price objective on Ardent Health from $24.00 to $20.00 and set an “overweight” rating for the company in a research note on Thursday, August 7th. Finally, Bank of America downgraded Ardent Health from a “neutral” rating to an “underperform” rating and decreased their target price for the stock from $15.50 to $14.60 in a research report on Wednesday, July 16th.

Institutional Investors Weigh In On Ardent Health

Large investors have recently added to or reduced their stakes in the business. Ameriprise Financial Inc. raised its position in Ardent Health by 75.6% during the second quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock worth $22,332,000 after acquiring an additional 703,739 shares during the last quarter. Vanguard Group Inc. grew its position in shares of Ardent Health by 368.9% in the first quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company’s stock valued at $18,296,000 after purchasing an additional 1,046,845 shares during the last quarter. Allspring Global Investments Holdings LLC increased its stake in shares of Ardent Health by 1.4% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 828,611 shares of the company’s stock worth $11,377,000 after purchasing an additional 11,429 shares in the last quarter. SageView Advisory Group LLC increased its stake in shares of Ardent Health by 367.2% during the 2nd quarter. SageView Advisory Group LLC now owns 790,663 shares of the company’s stock worth $10,800,000 after purchasing an additional 621,430 shares in the last quarter. Finally, Goldman Sachs Group Inc. raised its position in shares of Ardent Health by 1,684.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock worth $10,558,000 after purchasing an additional 724,841 shares during the last quarter.

Ardent Health Trading Up 0.4%

NYSE:ARDT opened at $14.10 on Friday. The stock has a fifty day moving average price of $12.98 and a two-hundred day moving average price of $13.05. The stock has a market capitalization of $2.02 billion, a price-to-earnings ratio of 7.79, a PEG ratio of 6.21 and a beta of 0.39. The company has a debt-to-equity ratio of 0.66, a quick ratio of 2.00 and a current ratio of 2.13. Ardent Health has a 1 year low of $10.10 and a 1 year high of $20.72.

Ardent Health (NYSE:ARDT) last issued its earnings results on Tuesday, August 5th. The company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.30 by $0.22. The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.54 billion. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. As a group, sell-side analysts anticipate that Ardent Health will post 1.23 earnings per share for the current fiscal year.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.